Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
SPOTLIGHT: Pump-stored Cubicin found tainted
Significant levels of an industrial chemical used to make rubber were found in Cubicin, an antibiotic made by Cubist Pharmaceuticals; the FDA said the contaminant showed up in Cubicin that had been in stored in Readymed drug pumps made by Cardinal Health, but not in batches of the drug stored in another type of infusion pump. Cubist recommended against using Readymed pumps with Cubicin, which accounted for $189.5 million in 2006 sales. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
